Latest News about REGN
Recent news which mentions REGN
This fund beats the S&P 500 by using just 75 of its components. Here’s how it works.
December 08, 2022
From MarketWatch
Chinese Lockdown Effects Ripple Marketwide; A Solution Urgently Needed
December 08, 2022
From Benzinga
Can These 2 Stocks Crush the Market Again in 2023?
December 04, 2022
From Motley Fool
Regeneron's Evkeeza Under FDA Priority Review For Younger Kids With Inherited Form Of High Cholesterol
November 30, 2022
Tickers
REGN
From Benzinga
UK Drug Regulator Warns Of Severe Eye Reactions Associated With Sanofi/Regeneron's Dupixent
November 30, 2022
From Benzinga
2 Market-Beating Stocks That Can Continue Rising in 2023
November 30, 2022
From Motley Fool
Cramer On This Stock Down 65% Year-To-Date: 'I Do Believe It's Bottoming, But I Don't Know What Gets It Higher'
November 18, 2022
From Benzinga
CytomX Shares Jump After Cancer Therapy Pact With Pharma Major Regeneron
November 17, 2022
From Benzinga
Why Is CytomX Therapeutics (CTMX) Stock Up 29% Today?
November 17, 2022
From InvestorPlace
Regeneron Pharmaceuticals's Return On Capital Employed Overview
November 17, 2022
Tickers
REGN
From Benzinga
2 Top Biotech Stocks to Buy in November
November 12, 2022
From Motley Fool
$100 Invested In This Stock 15 Years Ago Would Be Worth $4,000 Today
November 10, 2022
Tickers
REGN
From Benzinga
7 Cash-Rich Stocks to Buy for Peace of Mind
November 04, 2022
From InvestorPlace
Earnings Scheduled For November 3, 2022
November 03, 2022
From Benzinga
Here's How Much $1000 Invested In Regeneron Pharmaceuticals 15 Years Ago Would Be Worth Today
November 02, 2022
Tickers
REGN
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
From Benzinga
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For October 26, 2022
October 26, 2022
From Benzinga
From Motley Fool
2 Biotech Stocks You Can Buy and Hold for the Next Decade
October 18, 2022
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2022
October 17, 2022
From Benzinga
13 Analysts Have This to Say About Regeneron Pharmaceuticals
October 17, 2022
Tickers
REGN
From Benzinga
3 Red-Hot Stocks That Could Continue to Beat the Market
October 13, 2022
From Motley Fool
From Benzinga
Moderna, Eli Lilly And This Biotechnology Stock Insiders Are Selling
October 10, 2022
From Benzinga
These 7 Biotech Stocks Are Set to Boom in 2023
October 10, 2022
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.